Company and its subsidiaries as at September 30, 2019 total assets were Baht 3,780.28 million, divided into total current assets of Baht 960.33 million, non-current assets of Baht 2,819.95 million, total

deferred revenue amounting to THB 2,100.6 mm to statement of comprehensive income for this period. • Share of profit from power associates and joint ventures decreased by 53.0%, mainly due to the planned

OR "electrical asset" OR "electric property" OR "electric possession" OR "power property" OR "power possession"&wt=json&indent=true&facet=true&facet.field=key_filetype&facet.field=key_sitemap

that bolstered purchasing power. Government expenditure also plays important role in sustaining the economy with fixed expenses continuing to expand in comparison to the same period last year, especially

. As at 31 December 2018 the Company is current asset in which accounted for 55.7% of the total assets and non-current asset accounted for 44.3% of the total assets. THB MB % THB MB % Current assets

September 2017 totaled THB 626.4 MB and THB 1,115.5 MB respectively. The main assets held by the company is current asset in which accounted for 80% of the total assets and non-current asset accounted for 20

Company is current asset in which accounted for 50.5% of the total assets and non-current asset accounted for 49.5% of the total assets. THB MB % THB MB % Current assets 665.3 55.7 575.0 50.5 Non-current

assets as of 31 December 2019 and 30 June 2020 totaled THB 1,158.6 MB and THB 1,358.4 MB respectively. As at 30 June 2020 the Company is current asset in which accounted for 55.4% of the total assets and

shareholders and directors of Modern Pharma Company Limited are not Executive Committee and shareholders including those with controlling power in the company. Therefore, it is not considered a connected

in 31 December 2017. Current ratio as of the same date and period stood at 2.42x, a considerable improvement from 1.69x, both mainly as a result of the aforementioned capital increase SIGNIFICANT